Ingress prefers Rotterdam, but welcomes EMA to Amsterdam

Ingress-health is increasing involved in supporting comparative effectiveness submissions to EMA. For more information on how we can support you, please contact us here. The European Medicines Agency (EMA) is the institution responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union. Following Brexit, the agency is set to relocate

Lees meer

Paper published on Staphylococcus aureus infections in German type 2 diabetes mellitus patients

Our INGRESS colleagues Fraence Gottschalk, Thomas Wilke, and Sabrina Mueller have just published a new paper in the journal Surgical Infections Nov 2017, 18(8):915-923. Their claims data analysis shows the incidence of Staphylococcus aureus infections in German type 2 diabetes mellitus patients, undergoing an orthopedic knee, hip and spine surgery. Further, risk factors and clinical and health–economic outcomes

Lees meer